ClinicalTrials.gov
public full text
Public Domain
Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL)
Miltefosine efficacy will be \>85%
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis#127716
- Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis#851564
- Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar#853320
- Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis#261306
- Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly#1096180
Record · ID 1486595
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive